Stephen Williamson
Stephen Williamson
University of Kansas Cancer Center
Dirección de correo verificada de
Citado por
Citado por
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer
RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ...
Journal of Clinical Oncology 22 (1), 23-30, 2004
Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest …
AA Forastiere, B Metch, DE Schuller, JF Ensley, LF Hutchins, P Triozzi, ...
Journal of Clinical Oncology 10 (8), 1245-1251, 1992
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741
HK Sanoff, DJ Sargent, ME Campbell, RF Morton, CS Fuchs, ...
Journal of Clinical Oncology 26 (35), 5721, 2008
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with …
RM Goldberg, DJ Sargent, RF Morton, CS Fuchs, RK Ramanathan, ...
Journal of clinical oncology 24 (21), 3347-3353, 2006
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741
HL McLeod, DJ Sargent, S Marsh, EM Green, CR King, CS Fuchs, ...
Journal of clinical oncology 28 (20), 3227, 2010
Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144
SR Smalley, JK Benedetti, SK Williamson, JM Robertson, NC Estes, ...
Journal of Clinical Oncology 24 (22), 3542-3547, 2006
Unemployment insurance with moral hazard in a dynamic economy
C Wang, S Williamson
Carnegie-Rochester Conference Series on Public Policy 44, 1-41, 1996
Chemotherapy permits resection of metastatic colorectal cancer: experience from Intergroup N9741
T Delaunoit, SR Alberts, DJ Sargent, E Green, RM Goldberg, J Krook, ...
Annals of oncology 16 (3), 425-429, 2005
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non–small-cell lung cancer: A model for assessing population-related pharmacogenomics
DR Gandara, T Kawaguchi, J Crowley, J Moon, K Furuse, M Kawahara, ...
Journal of clinical oncology 27 (21), 3540, 2009
Disease control rate at 8 weeks predicts clinical benefit in advanced non–small-cell lung cancer: results from Southwest Oncology Group randomized trials
PN Lara Jr, MW Redman, K Kelly, MJ Edelman, SK Williamson, ...
Journal of Clinical Oncology 26 (3), 463-467, 2008
Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma: a Southwest …
SK Williamson, D Lew, GJ Miller, SP Balcerzak, LH Baker, ED Crawford
Cancer: Interdisciplinary International Journal of the American Cancer …, 2000
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420
SK Williamson, J Moon, CH Huang, PP Guaglianone, M LeBlanc, GT Wolf, ...
Journal of Clinical Oncology 28 (20), 3330, 2010
Tirapazamine: a novel agent targeting hypoxic tumor cells
SB Reddy, SK Williamson
Expert opinion on investigational drugs 18 (1), 77-87, 2009
Phase III trial of paclitaxel plus carboplatin with or without tirapazamine in advanced non–small-cell lung cancer: Southwest Oncology Group Trial S0003
SK Williamson, JJ Crowley, PN Lara Jr, J McCoy, DHM Lau, RW Tucker, ...
Journal of Clinical Oncology 23 (36), 9097-9104, 2005
N9741: oxaliplatin (Oxal) or CPT-11+ 5-fluorouracil/leucovorin or Oxal+ CTP-11 in advanced colorectal cancer. Updated efficacy and quality of life data from an intergroup study
RM Goldberg
Proc Am Soc Clin Oncol 22, 1009, 2003
N9741: oxaliplatin (oxal) or CPT-11+ 5-fluorouracil (5FU)/leucovorin (LV) or oxal+ CPT-11 in advanced colorectal cancer. Initial toxicity and response data from a GI Intergroup …
R Goldberg
Proc. Am Soc Clin Oncol 21, 128a (# 511), 2002
Lower osteopontin plasma levels are associated with superior outcomes in advanced non–small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG study S0003
PC Mack, MW Redman, K Chansky, SK Williamson, NC Farneth, ...
Journal of clinical oncology 26 (29), 4771, 2008
Treatment of vitamin D deficiency in patients with metastatic prostate cancer may improve bone pain and muscle strength
The Journal of urology 163 (1), 187-190, 2000
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741
GK Dy, JE Krook, EM Green, DJ Sargent, T Delaunoit, RF Morton, ...
Journal of clinical oncology 25 (23), 3469-3474, 2007
Phase 1 clinical trial of irradiated autologous melanoma cells adenovirally transduced with human GM-CSF gene
M Kusumoto, S Umeda, A Ikubo, Y Aoki, O Tawfik, R Oben, S Williamson, ...
Cancer Immunology, Immunotherapy 50 (7), 373-381, 2001
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20